ArticleSubstance abuse treatment, prevention, and policy2010
Persistence of low drug treatment coverage for injection drug users in large US metropolitan areas.
Article in Substance abuse treatment, prevention, and policy, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 22 citations in OpenAlex.
- The impact of restricted community accessibility on needle and syringe sharing among drug users in Baise city: based on the event study method.BMC public health · 2025Article
- Harm Reduction Behavioral Activation Teletherapy for People Who Inject Drugs: Development, Feasibility, and Acceptability.Cognitive and behavioral practice · 2024Article
- Conceptualizing the Socio-Built Environment: An Expanded Theoretical Framework to Promote a Better Understanding of Risk for Nonmedical Opioid Overdose Outcomes in Urban and Non-Urban Settings.Journal of urban health : bulletin of the New York Academy of Medicine · 2022Article
- Predictors of historical change in drug treatment coverage among people who inject drugs in 90 large metropolitan areas in the USA, 1993-2007.Substance abuse treatment, prevention, and policy · 2020Article
- Change and variability in drug treatment coverage among people who inject drugs in 90 large metropolitan areas in the USA, 1993-2007.Substance abuse treatment, prevention, and policy · 2018Article
- Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study.Harm reduction journal · 2017Article
- Income inequality, drug-related arrests, and the health of people who inject drugs: Reflections on seventeen years of research.The International journal on drug policy · 2016Article
- Do metropolitan HIV epidemic histories and programs for people who inject drugs and men who have sex with men predict AIDS incidence and mortality among heterosexuals?Annals of epidemiology · 2014Article
- A latent class approach to treatment readiness corresponds to a transtheoretical ("Stages of Change") model.Journal of substance abuse treatment · 2013Article
- How outpatient substance abuse treatment unit director activities may affect provision of community outreach services.Drugs (Abingdon, England) · 2013Article
- Trends in the population prevalence of people who inject drugs in US metropolitan areas 1992-2007.PloS one · 2013Article
- Article
- Problem recognition, intention to stop use, and treatment use among regular heroin injectors.Journal of substance abuse treatment · 2012Article
- Article
- Barriers to drug treatment for IDU couples: the need for couple-based approaches.Journal of addictive diseases · 2012Article
- Changes in the prevalence of injection drug use among adolescents and young adults in large U.S. metropolitan areas.AIDS and behavior · 2011Article
- The urgency of providing comprehensive and integrated treatment for substance abusers with HIV.Health affairs (Project Hope) · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
Abstract
objectivesInjection drug users (IDUs) are at high risk for HIV, hepatitis, overdose and other harms. Greater drug treatment availability has been shown to reduce these harms among IDUs. Yet, little is known about changes in drug treatment availability for IDUs in the U.S. This paper investigates change in drug treatment coverage for IDUs in 90 metropolitan statistical areas (MSAs) during 1993-2002.
methodsWe define treatment coverage as the percent of IDUs who are in treatment. The number of IDUs in drug treatment is calculated from treatment entry data and treatment census data acquired from the Substance Abuse and Mental Health Service Administration, divided by our estimated number of IDUs in each MSA.
resultsTreatment coverage was low in 1993 (mean 6.7%; median 6.0%) and only increased to a mean of 8.3% and median of 8.0% coverage in 2002.
conclusionsAlthough some MSAs experienced increases in treatment coverage over time, overall levels of coverage were low. The persistence of low drug treatment coverage for IDUs represents a failure by the U.S. health care system to prevent avoidable harms and unnecessary deaths in this population. Policy makers should expand drug treatment for IDUs to reduce blood-borne infections and community harms associated with untreated injection drug use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.